Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Añadir filtros








Intervalo de año
1.
Rev. méd. Chile ; 139(1): 89-99, ene. 2011. ilus
Artículo en Español | LILACS | ID: lil-595271

RESUMEN

Tamoxifen is used as an adjuvant therapy to reduce breast cáncer recurrence among women with estrogenreceptor positive tumors. Antidepressants are also com-monly used in such women, to treat depression or to manage hotflush.es, afrequent tamoxifen secondary effect. Some antidepressants couldpotentially inhibit cytochrome P450 2D6, required to actívate tamoxifen, interfering with its action. Although there is not a clear cut directive on the subject, it is nowadays recommended to treat women with antidepressants with the lower cytochrome P450 2D6 inhibition potential to avoid apossible antagonism that may reduce tamoxifen s prevention of breast cáncer recurrence at least in some patients with CYP2D6 genetic variation. The recommended antidepressants are desvenlafaxine, milnacipran, venlafaxin, escitalopram and citalopram.


Asunto(s)
Femenino , Humanos , Antidepresivos/efectos adversos , Neoplasias de la Mama/tratamiento farmacológico , /antagonistas & inhibidores , Antagonistas de Estrógenos/metabolismo , Tamoxifeno/metabolismo , Antidepresivos/farmacología , /genética , Interacciones Farmacológicas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA